SOLAZYME INC·4

Jan 23, 5:07 PM ET

Dillon Harrison 4

4 · SOLAZYME INC · Filed Jan 23, 2013

Insider Transaction Report

Form 4
Period: 2013-01-18
Dillon Harrison
DirectorCTO and President
Transactions
  • Exercise/Conversion

    Common Stock

    2013-01-18$0.13/sh+133,600$17,6352,168,984 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-01-18100,0000 total
    Exercise: $0.13From: 2008-02-08Exp: 2013-02-07Common Stock (100,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-01-1833,6000 total
    Exercise: $0.13From: 2008-02-08Exp: 2013-02-07Common Stock (33,600 underlying)

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT